Viewing Study NCT02790034


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-03-09 @ 3:29 AM
Study NCT ID: NCT02790034
Status: TERMINATED
Last Update Posted: 2021-12-21
First Post: 2016-05-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
Sponsor: Newron Pharmaceuticals SPA
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: Sarizotan/001/II/2015
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators